E-LIB Suche - Ergebnisse für: Schulberg, Julien

1

High Technical Success Rate of Endoscopic Balloon Dilatatio..:

Lim, Emily ; Thai, Maxter ; An, Yoon-Kyo...
GastroHep. 2024 (2024) 1 - p. , 2024

Link: https://doi.org/10.1155/..

2

Su1777 CROHN'S DISEASE STRICTURES RESPOND TO ADALIMUMAB DRU..:

Lovett, Grace C. ; Schulberg, Julien D. ; Hamilton, Amy L....
Gastroenterology. 166 (2024) 5 - p. S-809 , 2024

Link: https://doi.org/10.1016/..

3

Poor prognostic factors of pharmacokinetic origin predict o..:

Spencer, Elizabeth A. ; Dubinsky, Marla C. ; Kamm, Michael A....
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

4

Su1826 SUSTAINED PRESENCE OF PHARMACOKINETIC PREDICTIVE FAC..:

Kamm, Michael A. ; Chaparro, María ; Hamilton, Amy L....
Gastroenterology. 166 (2024) 5 - p. S-831 , 2024

Link: https://doi.org/10.1016/..

5

Mo1817 IMPROVED CLINICAL AND RADIOLOGIC HEALING OF CROHN'S ..:

De Gregorio, Michael ; Winata, Leon Shin-han ; Hartley, Imogen...
Gastroenterology. 166 (2024) 5 - p. S-1126-S-1127 , 2024

Link: https://doi.org/10.1016/..

6

Su1815 POOR PROGNOSTIC FACTORS OF PHARMACOKINETIC ORIGIN PR..:

Spencer, Elizabeth A. ; Dervieux, Thierry ; Kamm, Michael A....
Gastroenterology. 166 (2024) 5 - p. S-826-S-827 , 2024

Link: https://doi.org/10.1016/..

7

Corrigendum: Poor prognostic factors of pharmacokinetic ori..:

Spencer, Elizabeth A. ; Dubinsky, Marla C. ; Kamm, Michael A....
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

8

DataSheet_1_Poor prognostic factors of pharmacokinetic orig..:

Elizabeth A. Spencer ; Marla C. Dubinsky ; Michael A. Kamm...
https://figshare.com/articles/dataset/DataSheet_1_Poor_prognostic_factors_of_pharmacokinetic_origin_predict_outcomes_in_inflammatory_bowel_disease_patients_treated_with_anti-tumor_necrosis_factor-_docx/25298869. , 2024

Link: https://doi.org/10.3389/..

9

Poor prognostic factors of pharmacokinetic origin predict o..:

Elizabeth A. Spencer ; Marla C. Dubinsky ; Michael A. Kamm...
https://www.frontiersin.org/articles/10.3389/fimmu.2024.1342477/full. , 2024

Link: https://doi.org/10.3389/..

10

DataSheet_1_Poor prognostic factors of pharmacokinetic orig..:

Elizabeth A. Spencer ; Marla C. Dubinsky ; Michael A. Kamm...
doi:10.3389/fimmu.2024.1342477.s001. , 2024

Link: https://doi.org/10.3389/..

11

DataSheet_1_Poor prognostic factors of pharmacokinetic orig..:

Elizabeth A. Spencer ; Marla C. Dubinsky ; Michael A. Kamm...
doi:10.3389/fimmu.2024.1342477.s001. , 2024

Link: https://doi.org/10.3389/..

12

Risk factors for malignancy and serious infection in patien..:

Tassone, Daniel ; Basnayake, Chamara ; Wright, Emily...
Internal Medicine Journal. 54 (2023) 3 - p. 446-454 , 2023

Link: https://doi.org/10.1111/..

13

Relationship Between Serum Ustekinumab Trough Concentration..:

Nguyen, Khue M. ; Mattoo, Vandita Y. ; Vogrin, Sara...
European Journal of Drug Metabolism and Pharmacokinetics. 48 (2023) 3 - p. 271-279 , 2023

Link: https://doi.org/10.1007/..

14

Outcomes of a Comprehensive Specialist Inflammatory Bowel D..:

Yu, Natalie ; Wu, Kyle ; Samyue, Tamie...
Inflammatory Bowel Diseases. 30 (2023) 6 - p. 960-969 , 2023

Link: https://doi.org/10.1093/..

15

Novel Use of the Crohn's Disease Exclusion Diet Plus Partia..:

Ukovic, Bianca ; Chapman, Brooke ; Schulberg, Julien..
ACG Case Reports Journal. 10 (2023) 7 - p. e01078 , 2023

Link: https://doi.org/10.14309..